Brief: Shineco Inc To Acquire Controlling Equity Interest In Changzhou Biowin Pharmaceutical Co Ltd
25/10/2022 17:52
Oct 25 (Reuters) - Shineco Inc SISI.O :
* SHINECO, INC. TO ACQUIRE CONTROLLING EQUITY INTEREST IN
CHANGZHOU BIOWIN PHARMACEUTICAL CO., LTD TO STEP INTO
POINT-OF-CARE TESTING INDUSTRY
Source text for Eikon: ID:nGNX1hR4NJ
Further company coverage: SISI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shineco
See all newsBrief: Shineco Unveils World's First On-Chain Cell Asset Tokenization Platform Strategic Acquisition Expands Global Blockchain-Biotech Network
Brief: Shineco Establishes Biological Cell Digital Division to Integrate Biological Cell Assets and Blockchain Technology
Brief: Shineco Inc To Effect 50:1 Reverse Stock Split
Brief: Shineco Inc - To Sell 18 Million Shares At $0.75 Each
Brief: Shineco Announces Acquisition Of Singapore Evolutionary Stem Cell Company